Polydex Pharmaceuticals Issues Third Quarter Financial Results
TORONTO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the third quarter of fiscal 2023, the period ended October 31, 2022. All figures are reported in U.S. dollars.
- Although results for the current quarter continue to reflect a soft market and persisting problems with the global economy as a whole, a number of product orders filled in the third quarter weren’t shipped until the fourth quarter, resulting in lower sales this quarter.
- Management’s continued cautious approach to cash management has allowed the company to weather these worldwide issues.
- The company continues full disclosure of its financial and operational results, which can be accessed by visiting the company website at www.Polydex.com .
- Other risk factors discussed in the Company’s financial reports may also affect the actual results achieved by the Company.